Intellia Therapeutics (NTLA) FCF/share US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -3.35 | -5.09 | -4.60 | -3.59 | -3.27 | -3.07 | |||
| Changes by years, y/y, % | +251% | +52% | -10% | -22% | -9% | +27.9% | |||
Intellia Therapeutics. FCF/share, rub
Intellia Therapeutics. FCF/share, changes, %
Intellia Therapeutics (NTLA) FCF/share US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| FCF/share, rub | -1.45 | -0.96 | -0.70 | -0.64 | -0.99 | -3.07 | ||
| Changes by years, y/y, % | +12% | +58% | -18% | -24% | -31% | |||
| Changes by quarters, q/q, % | +71% | -33% | -27% | -8% | +55% | |||